Comparison of Contamination Levels on the Exterior Surfaces of Vials Containing Platinum Anticancer Drugs in Japan

DOI Web Site Web Site PubMed 被引用文献1件 参考文献13件
  • Naito Takafumi
    Department of Hospital Pharmacy, School of Medicine, Hamamatsu University
  • Osawa Takashi
    Department of Hospital Pharmacy, School of Medicine, Hamamatsu University
  • Suzuki Naoya
    Department of Hospital Pharmacy, School of Medicine, Hamamatsu University Department of Clinical Pharmaceutics, Faculty of Pharmaceutical Sciences, Setsunan University
  • Goto Toshiya
    Department of Pharmacy, Iwata City Hospital
  • Takada Akira
    Department of Pharmacy, Iwata City Hospital
  • Nakamichi Hidenori
    Department of Pharmacy, Seirei Hamamatsu General Hospital
  • Onuki Yoshiko
    Department of Pharmacy, Seirei Hamamatsu General Hospital
  • Imai Kimie
    Department of Clinical Pharmaceutics, Faculty of Pharmaceutical Sciences, Setsunan University
  • Nakanishi Kunio
    Department of Clinical Pharmaceutics, Faculty of Pharmaceutical Sciences, Setsunan University
  • Kawakami Junichi
    Department of Hospital Pharmacy, School of Medicine, Hamamatsu University

この論文をさがす

抄録

Contamination of the external surface of anticancer drug vials supplied to hospital pharmacies has been recognized as a potential health hazard. The aim of this study was to investigate the levels of contamination on the exterior surface of vials containing platinum anticancer drugs in Japan. Platinum contamination on the exterior surface of vials containing cisplatin or carboplatin was examined using products commercially available in Japan. Cisplatin vials from 42 batches (2 drug contents, 10 products and 5 manufacturers) and carboplatin vials from 28 batches (3 drug contents, 7 products and 3 manufacturers) were used. Five vials were randomly sampled from each batch. Exterior contamination levels of 0.070–144 ng/vial as cisplatin and 0.21–1630 ng/vial as carboplatin were detected. Significant differences in the levels of contamination among the batch numbers were observed in 6 of 10 cisplatin products and 6 of 7 carboplatin products. Significant differences in the levels of contamination were observed in 3 cisplatin products with different contents of drug within the vials and 1 carboplatin product with different contents of drug within the vials. Significant differences in the contamination levels among the cisplatin manufacturers but not carboplatin manufacturers were observed. The degree of contamination of the carboplatin products was significantly higher than that of the cisplatin products. In conclusion, external contamination was confirmed in all cisplatin and carboplatin vials tested. The degree of contamination was different among different batch numbers, drug contents, manufacturers, and platinum anticancer drug.

収録刊行物

被引用文献 (1)*注記

もっと見る

参考文献 (13)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ